Product Images Memantine Hydrochloride

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Memantine Hydrochloride NDC 71335-1863 by Bryant Ranch Prepack, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

image description - celltrion logo

image description - celltrion logo

Label - lbl713351863

Label - lbl713351863

This is a description of a medication called "Namenda" with a dosage of 10mg per tablet. The medication has been packaged by a company called "Bryant Ranck Prepack" and compared to a similar medication made by "Vivimed Life Sciences Private." The package contains 30 tablets, and the expiration date is indicated by "EXP MM/YY." The National Drug Code (NDC) for the medication is 7133518631. The medication should be stored at room temperature, and caution must be taken to keep it out of reach of children. There is a barcode number present as well.*

structure - memantinehcltab figure 01

structure - memantinehcltab figure 01

figure1 - memantinehcltab figure 02

figure1 - memantinehcltab figure 02

The given text appears to be a table, showing the mean change (and SEM) in ADCS-ADL score after 12 weeks of treatment with either placebo or memantine HCl. The table also indicates that there was clinical improvement in both groups (however, without any specific numeric values).*

figure2 - memantinehcltab figure 03

figure2 - memantinehcltab figure 03

This appears to be a chart or graph displaying the cumulative percentage of patients and their ADCS-ADL Change from Baseline, with two lines for the drugs Placebo and Memantine HCI. The x-axis shows negative values for change from baseline, indicating a decline in patient function, while the y-axis displays percentages from 0 to 100. However, without more context or information, the purpose of this graph is not entirely clear.*

figure3 - memantinehcltab figure 04

figure3 - memantinehcltab figure 04

figure4 - memantinehcltab figure 05

figure4 - memantinehcltab figure 05

This appears to be a chart or graph showing the cumulative percentage of patients and their response to a placebo and memantine HCI in relation to a change from baseline. The x-axis likely represents the percentage of patients and the y-axis represents the change from baseline. Without more context or a clearer image, further analysis or interpretation is not possible.*

figure5 - memantinehcltab figure 06

figure5 - memantinehcltab figure 06

figure6 - memantinehcltab figure 07

figure6 - memantinehcltab figure 07

figure7 - memantinehcltab figure 08

figure7 - memantinehcltab figure 08

figure8 - memantinehcltab figure 09

figure8 - memantinehcltab figure 09

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.